The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A case-control study of community-associated Clostridium difficile infection
Open accessAbstract
OBJECTIVES: The aim of this study was to determine the incidence of and risk factors for community-associated Clostridium difficile infection (CDI). METHODS: Prospective surveillance of community-derived faecal samples for C. difficile cytotoxin, followed by a questionnaire-based case-control study in two distinct patient cohorts (one semi-rural and the other urban). RESULTS: The proportion of randomly selected faecal samples positive for C. difficile cytotoxin was 2.1% in both patient cohorts (median ages 73 and 45 years for the urban and semi-rural cohorts, respectively). Exposure to antibiotics in the previous 4 weeks, particularly multiple agents (P < 0.001), aminopenicillins (P < 0.05) and oral cephalosporins (P < 0.05), was significantly more frequent among cases than controls. Hospitalization in the preceding 6 months was significantly associated with CDI (45% versus 23%; P = 0.022). However, almost half the cases had not received antibiotic therapy in the month before C. difficile detection, and approximately one-third neither had exposure to antibiotics nor recent hospitalization. Contact with infants aged < or =2 years was significantly associated with CDI (14% versus 2%; P = 0.02). Prior exposure to gastrointestinal-acting drugs (proton pump inhibitor, H2 antagonist or non-steroidal anti-inflammatory) was not significantly more common in CDI cases. C. difficile PCR ribotype 001 caused 60% and 13% of urban and semi-rural community-associated CDI cases, respectively. CONCLUSIONS: Reliance on antibiotic history and age (> or =65 years) will contribute to missed diagnoses of community-associated CDI. Potential risk factors for community-associated CDI should be explored further to explain the large proportion of cases not linked to recent antibiotic therapy or hospitalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Wheeler, J. G., Sethi, D., Cowden, J. M., Wall, P. G., Rodrigues, L. C., Tompkins, D. S., Hudson, M. J., & Roderick, P. J. (1999) · BMJ · doi:10.1136/bmj.318.7190.1046 · Cited by 794
Financial burden of hospital-acquired Clostridium difficile infection
Wilcox, M. H., Cunniffe, J. G., Trundle, C., & Redpath, C. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90122-x · Cited by 244
Self-citationEpidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Dial, S. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060284 · Cited by 218
Clostridium difficile in Long-Term–Care Facilities for the Elderly
Simor, A. E., Bradley, S. F., Strausbaugh, L. J., Crossley, K., Nicolle, L. E., & SHEA Long-Term–Care Committee (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/501997 · Cited by 218
A Prospective Nationwide Study of Clostridium difficile‐Associated Diarrhea in Sweden
Karlström, O. H., Fryklund, B. A., Tullus, K., BURMAN, L. G., & the Swedish C. difficile Study Group (1998) · Clinical Infectious Diseases · doi:10.1086/516277 · Cited by 177
Norén, T., Åkerlund, T., Bäck, E., Sjöberg, L., Persson, I., Alriksson, I., & Burman, L. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3635-3643.2004 · Cited by 160
Lowe, D. O., Mamdani, M. M., Kopp, A., Low, D. E., & Juurlink, D. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508453 · Cited by 156
Factors associated with prolonged symptoms and severe disease due to Clostridium difficile
Kyne, L., Merry, C., O'Connell, B., Kelly, A., Keane, C., & O'Neill, D. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.107 · Cited by 154
Clostridium difficile toxin in asymptomatic neonates
Behrman, R. E., Donta, S. T., & Myers, M. G. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80454-x · Cited by 148
Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea
YEARSLEY, K. A., GILBY, L. J., Ramadas, A., Kubiak, E., Fone, D. L., & Allison, M. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03015.x · Cited by 145
Albumin, Length of Stay, and Proton Pump Inhibitors
Al-Tureihi, F. I. J., Hassoun, A., Wolf‐Klein, G. P., & Isenberg, H. D. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.01.003 · Cited by 116
Recovery of Clostridium difficile from Children
Holst, E., HELIN, I., & Mårdh, P. (1981) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365548.1981.11690365 · Cited by 114
Matsuki, S., Ozaki, E., Shozu, M., Inoue, M., Shimizu, S., Yamaguchi, N., Karasawa, T., Yamagishi, T., & Nakamura, S. (2005) · PubMed · Cited by 110
Antibiotic‐associated diarrhoea and Clostridium difficile> in the community
Beaugerie, L., Flahault, A., Barbut, F., Atlan, P., Lalande, V., Cousin, P., Cadilhac, M., Petit, J., & FOR THE STUDY GROUP (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01531.x · Cited by 107
Prevalence surveys of healthcare-associated infections: what do they tell us, if anything?
Humphreys, H., & Smyth, E. T. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01273.x · Cited by 94
Palmore, T. N., Sohn, S., Malak, S. F., Eagan, J. A., & Sepkowitz, K. A. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502602 · Cited by 93
Molecular epidemiology of endemic Clostridium difficile infection
Fawley, W. N., & Wilcox, M. H. (2001) · Epidemiology and Infection · doi:10.1017/s095026880100557x · Cited by 88
Self-citationAntibiotics and Clostridium difficile diarrhea in the ambulatory care setting
Levy, D. G., Stergachis, A. S., McFarland, L. V., Vorst, K. V., Graham, D. J., Johnson, E. S., Park, B., Shatin, D., Clause, J. C., & Elmer, G. W. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)87980-1 · Cited by 87
Community-Acquired Clostridium difficile-Associated Diarrhea
Riley, T. V., Cooper, M., Bell, B., & Golledge, C. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s263 · Cited by 79
National Clostridium difficile Standards Group: Report to the Department of Health
(2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.10.016 · Cited by 74
Weightman, N. C., & Lines, L. D. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.09.006 · Cited by 70
Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes
Alonso, M. A. S., Ramos, I. J., Salavert, M., et al. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01602.x · Cited by 55
Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile -Associated Disease?
Dhalla, I. A., Mamdani, M., Simor, A. E., Kopp, A., Rochon, P. A., & Juurlink, D. N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-06 · Cited by 48
Clostridium difficilein general practice and community health
Riley, T. V., Wymer, V., Bamford, V. W., & Bowman, R. A. (1986) · Journal of Hygiene · doi:10.1017/s0022172400062483 · Cited by 26
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Self-citationBurden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Self-citation
Metadata
- Authors
- Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-31
- Volume
- 62
- Issue
- 2
- Pages
- 388-396
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2128490444
- Cited by
- 372
- References
- 29
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.